Lumida
/MYO
⌘K
Myomo Inc

Myomo Inc

MYO
$1.30USD+0.00%+0.00 today

MARKET CAP

51.5M

P/E (TTM)

FWD P/E

DAY RANGE

$1 – $1

52W RANGE

$1
$2

AI Summary

Stalk
Sell NowMedium

MYO is in a Stage 4 decline, forming clear lower highs and lower lows under declining EMAs. Price is holding around the 9EMA/20EMA zone with no exhaustion or mean-reversion signals, and volume favors downside continuation. Both short-term and medium-term biases are bearish, and timing conditions support immediate participation at resistance around the short EMAs. The long-term downtrend is confirmed by a declining 200-day SMA. Only a sustained reclaim and close above the 20EMA would invalidate this bearish posture.

  • Fair value estimate climbed from $1.10 to $1.70 on expected margin improvements.
  • Q3 earnings projections upgraded, reflecting better operational outlook.
  • Earnings yield is deeply negative, highlighting poor return potential.
Full analysis →
Insider Trades56 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Aug 7, 2026SellMYOMicah MitchellChief Commercial Officer21,559$1.42$51.5M-31.03%+114.88%$30.6K-14.16%Sell Now
Aug 7, 2026SellMYOHarry KovelmanChief Medical Officer22,457$1.42$51.5M-31.03%+114.88%$31.9K-15.41%Sell Now
Aug 7, 2026SellMYODavid A HenryChief Financial Officer25,310$1.42$51.5M-31.03%+114.88%$35.9K-5.11%Sell Now
Jul 13, 2026SellMYODavid A HenryChief Financial Officer5,166$1.09$51.5M-31.03%+114.88%$5.6K-1.20%Sell Now
Jun 12, 2026SellMYOMicah MitchellChief Commercial Officer9,061$1.20$51.5M-31.03%+114.88%$10.9K-8.80%Sell Now
Jun 12, 2026SellMYOHarry KovelmanChief Medical Officer10,442$1.20$51.5M-31.03%+114.88%$12.5K-10.34%Sell Now
Jun 12, 2026SellMYODavid A HenryChief Financial Officer10,969$1.15$51.5M-31.03%+114.88%$12.6K-2.52%Sell Now
Jun 8, 2026SellMYOMicah MitchellChief Commercial Officer6,529$1.33$51.5M-31.03%+114.88%$8.7K-5.96%Sell Now
Jun 8, 2026SellMYOHarry KovelmanChief Medical Officer7,635$1.33$51.5M-31.03%+114.88%$10.2K-7.03%Sell Now
Jun 8, 2026SellMYODavid A HenryChief Financial Officer10,050$1.28$51.5M-31.03%+114.88%$12.9K-2.26%Sell Now
May 27, 2026SellMYOHarry KovelmanChief Medical Officer32,000$1.01$51.5M-31.03%+114.88%$32.2K-12.27%Sell Now
May 14, 2026SellMYOMicah MitchellChief Commercial Officer90,231$0.86$51.5M-31.03%+114.88%$77.7K-45.18%Sell Now
Apr 13, 2026SellMYODavid A HenryChief Financial Officer3,953$0.71$51.5M-31.03%+114.88%$2.8K-0.88%Sell Now
Sep 9, 2025SellMYOPaul R GudonisChief Executive Officer10,000$0.95$51.5M-31.03%+114.88%$9.5K-0.79%Sell Now
Aug 15, 2025BuyMYOPaul R GudonisChief Executive Officer50,000$0.95$51.5M-31.03%+114.88%$47.3K+4.14%Sell Now
Jun 30, 2025SellMYOHarry KovelmanChief Medical Officer13,054$2.19$51.5M-31.03%+114.88%$28.6K-8.49%Sell Now
Jun 30, 2025SellMYODavid A HenryChief Financial Officer23,587$2.19$51.5M-31.03%+114.88%$51.7K-5.22%Sell Now
Jun 6, 2025SellMYOHarry KovelmanChief Medical Officer5,743$2.97$51.5M-31.03%+114.88%$17.1K-5.95%Sell Now
Jun 6, 2025SellMYODavid A HenryChief Financial Officer8,373$2.97$51.5M-31.03%+114.88%$24.9K-2.18%Sell Now
May 15, 2025BuyMYOPaul R GudonisChief Executive Officer30,000$3.22$51.5M-31.03%+114.88%$96.6K+2.94%Sell Now
May 14, 2025SellMYOMicah MitchellChief Commercial Officer90,231$0.86$51.5M-31.03%+114.88%$77.7K-45.18%Sell Now
Mar 14, 2025SellMYOMicah MitchellChief Commercial Officer48,000$5.16$51.5M-31.03%+114.88%$247.6K-25.45%Sell Now
Mar 14, 2025SellMYOMicah MitchellChief Commercial Officer48,000$5.16$51.5M-31.03%+114.88%$247.6K-25.45%Sell Now
Mar 14, 2025SellMYOMicah MitchellChief Commercial Officer48,000$5.16$51.5M-31.03%+114.88%$247.6K-25.50%Sell Now
Mar 13, 2025SellMYOMicah MitchellChief Commercial Officer1,283$5.22$51.5M-31.03%+114.88%$6.7K-0.68%Sell Now
Mar 13, 2025SellMYOMicah MitchellChief Commercial Officer1,283$5.22$51.5M-31.03%+114.88%$6.7K-0.68%Sell Now
Mar 13, 2025SellMYODavid A HenryChief Financial Officer2,019$5.22$51.5M-31.03%+114.88%$10.5K-0.52%Sell Now
Mar 12, 2025SellMYOHarry KovelmanChief Medical Officer31,496$5.49$51.5M-31.03%+114.88%$172.8K-13.94%Sell Now
Feb 13, 2025BuyMYOPaul R GudonisChief Executive Officer694$0.05$51.5M-31.03%+114.88%$33.312+0.07%Sell Now
Nov 4, 2024SellMYOHarry KovelmanChief Medical Officer121$3.70$51.5M-31.03%+114.88%$447.7-0.10%Sell Now
Oct 3, 2024SellMYOHarry KovelmanChief Medical Officer121$3.86$51.5M-31.03%+114.88%$467.06-0.10%Sell Now
Sep 5, 2024SellMYOHarry KovelmanChief Medical Officer6,700$3.76$51.5M-31.03%+114.88%$25.2K-5.14%Sell Now
Sep 3, 2024SellMYOHarry KovelmanChief Medical Officer2,168$4.00$51.5M-31.03%+114.88%$8.7K-0.82%Sell Now
Aug 5, 2024SellMYOHarry KovelmanChief Medical Officer128$3.96$51.5M-31.03%+114.88%$506.88-0.10%Sell Now
Jul 3, 2024SellMYOHarry KovelmanChief Medical Officer121$2.85$51.5M-31.03%+114.88%$344.85-0.09%Sell Now
Jul 1, 2024SellMYOHarry KovelmanChief Medical Officer12,868$3.02$51.5M-31.03%+114.88%$38.9K-8.84%Sell Now
Jul 1, 2024SellMYOMicah MitchellChief Commercial Officer15,500$3.02$51.5M-31.03%+114.88%$46.8K-7.77%Sell Now
Jul 1, 2024SellMYODavid A HenryChief Financial Officer25,436$3.02$51.5M-31.03%+114.88%$76.8K-6.30%Sell Now
Jun 10, 2024SellMYOHarry KovelmanChief Medical Officer5,347$3.38$51.5M-31.03%+114.88%$18.1K-3.54%Sell Now
Jun 10, 2024SellMYOHarry KovelmanChief Medical Officer5,347$3.38$51.5M-31.03%+114.88%$18.1K-3.54%Sell Now
Jun 10, 2024SellMYOMicah MitchellChief Commercial Officer6,837$3.38$51.5M-31.03%+114.88%$23.1K-3.31%Sell Now
Jun 10, 2024SellMYOMicah MitchellChief Commercial Officer6,837$3.38$51.5M-31.03%+114.88%$23.1K-3.31%Sell Now
Jun 10, 2024SellMYODavid A HenryChief Financial Officer10,620$3.38$51.5M-31.03%+114.88%$35.9K-2.56%Sell Now
Jun 3, 2024SellMYOHarry KovelmanChief Medical Officer121$3.48$51.5M-31.03%+114.88%$421.08-0.12%Sell Now
May 15, 2024SellMYOHarry KovelmanChief Medical Officer35,426$3.69$51.5M-31.03%+114.88%$130.8K-26.55%Sell Now
May 3, 2024SellMYOHarry KovelmanChief Medical Officer146$3.84$51.5M-31.03%+114.88%$560.64-0.11%Sell Now
Apr 3, 2024SellMYOHarry KovelmanChief Medical Officer146$2.97$51.5M-31.03%+114.88%$433.62-0.11%Sell Now
Mar 11, 2024SellMYOMicah MitchellChief Commercial Officer5,359$3.51$51.5M-31.03%+114.88%$18.8K-3.31%Sell Now
Mar 11, 2024SellMYOHarry KovelmanChief Medical Officer6,590$3.51$51.5M-31.03%+114.88%$23.1K-4.70%Sell Now
Mar 11, 2024SellMYODavid A HenryChief Financial Officer7,774$3.51$51.5M-31.03%+114.88%$27.3K-2.21%Sell Now
Mar 5, 2024SellMYOHarry KovelmanChief Medical Officer147$3.88$51.5M-31.03%+114.88%$570.36-0.10%Sell Now
Feb 5, 2024SellMYOHarry KovelmanChief Medical Officer146$3.21$51.5M-31.03%+114.88%$468.66-0.10%Sell Now
Jan 3, 2024SellMYOHarry KovelmanChief Medical Officer145$4.69$51.5M-31.03%+114.88%$680.05-0.10%Sell Now
Dec 5, 2023SellMYOHarry KovelmanChief Medical Officer99$4.02$51.5M-31.03%+114.88%$397.98-0.07%Sell Now
Nov 6, 2023SellMYOHarry KovelmanChief Medical Officer121$1.41$51.5M-31.03%+114.88%$170.61-0.08%Sell Now
Oct 3, 2023SellMYOHarry KovelmanChief Medical Officer123$1.10$51.5M-31.03%+114.88%$135.3-0.08%Sell Now